WO1992017778A1 - Analytical devices - Google Patents

Analytical devices Download PDF

Info

Publication number
WO1992017778A1
WO1992017778A1 PCT/GB1992/000576 GB9200576W WO9217778A1 WO 1992017778 A1 WO1992017778 A1 WO 1992017778A1 GB 9200576 W GB9200576 W GB 9200576W WO 9217778 A1 WO9217778 A1 WO 9217778A1
Authority
WO
WIPO (PCT)
Prior art keywords
enclosure
electrode assembly
reactor
reactor according
base
Prior art date
Application number
PCT/GB1992/000576
Other languages
French (fr)
Inventor
Robert Wilson
Original Assignee
Robert Wilson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Wilson filed Critical Robert Wilson
Priority to JP4506950A priority Critical patent/JPH06506144A/en
Publication of WO1992017778A1 publication Critical patent/WO1992017778A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0645—Electrodes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0825—Test strips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces

Definitions

  • These devices are preferably of a self-contained form, typically requiring only the application of a sample of a body fluid such as urine or blood, for example.
  • the devices are mostly of a qualitative or semi-qualitative form requiring some ability on the part of the user to interpret the analytical result. Because the user is commonly not skilled for this last purpose, and in fact is often a lay individual, the user-dependent nature of the devices makes them less than completely satisfactory.
  • the present invention particularly concerns quantitative devices of a two-part form involving a reusable instrument co-operable with disposable analytical reactors. More particularly, the invention concerns such two-part devices in which the reactor involves a body of capillary material carrying at least one immobilised reagent and engaging an electrode assembly connectable with an associated instrument.
  • the reactor involves a body of capillary material carrying at least one immobilised reagent and engaging an electrode assembly connectable with an associated instrument.
  • a sample for analysis, and liquid to mobilise the reagent or reagents are applied to the capillary body and the resultant reaction influences the electrode assembly in a manner dependent on the sample to provide a related quantitative output from the instrument.
  • Such a device and use offers several advantages but, as so far proposed, also suffers from some disadvantages associated with the capillary body.
  • reagent can be mobilised in an undesirable manner to create areas of significantly different reagent concentrations.
  • Another disadvantage is that, if the mobilising liquid is applied by dipping the body into a liquid reservoir, which is attractive for its simplicity, reagent can be leached from the body into the reservoir and impair the desired reaction.
  • a further disadvantage is that the liquid contents of the body can be adversely affected by movement of the body such as occur, for example, with dipping.
  • An object of the present invention is to reduce these disadvantages and, to this end, the invention provides a disposable reactor for use with a co-operable instrument to form a quantitative analytical device, the reactor comprising a body of capillary material, a liquid-impermeable enclosure housing the capillary body and having an opening for application of liquid to the body, at least one reagent immobilised within the enclosure, and an electrode assembly passing through the enclosure, with one portion of the assembly extending within the enclosure to engage the capillary body and another portion of the assembly extending outside the enclosure, remotely from the enclosure opening, for connection with the associated instrument.
  • a reagent can be immobilised in the enclosure by impregnation or other incorporation in the capillary body and/or by deposition on or other incorporation in the interior of the enclosure.
  • the enclosure and the housed capillary body are of an elongate form with the opening at one end of the enclosure and the electrode assembly passing through the opposite end.
  • a form suitably involves a strip base for the enclosure, an electrode assembly extending longitudinally along one side face of the base, a capillary body also of strip form and located on the base as well as one end portion, but not the other, of the electrode assembly, and an enclosure cover extending transversely over the body and connected with the base while leaving the electrode assembly other end portion exposed.
  • the electrode assembly can in fact be directly covered with a layer of electrically insulating material over much of its length provided that it is exposed towards its ends respectively for operable engagement with the capillary body and an associated instrument.
  • Figure 1 schematically illustrates in exploded manner one form of a reactor according to the invention together with an associated instrument.
  • Figure 2 illustrates the results obtained for one form of ana tical assay effected with a particular embodiment of the reactor of Figure 1 ,
  • FIG. 3 illustrates the reactions involved in another form of assay
  • Figure 4 illustrates results obtained for the assay of Figure 3 with another reactor embodiment
  • Figures 5 and 6 respectively illustrate yet another assay and results associated with a further reactor embodiment.
  • FIG. 1 the reactor and associated instrument are denoted general ly at 10 and 20.
  • the reactor 10 has a base 11 of strip form made of material which is liquid impermeable and electrically insulating.
  • An electrode assembly consisting of two mutually spaced parallel electrodes 12 are mounted longitudinally on one face of the base and have an intermediate portion of their length covered by a layer 13 of further impermeable insulating material to leave the electrodes exposed at their extremities.
  • a body 14 of capillary material is, in turn, located to cover the exposed electrodes at one extremity.
  • the body 14 is itself covered by a further layer 15 of impermeable insulating material which extends transversely round the body to connect with the base, while leaving exposed the end of the body remote from layer 13.
  • at least one reagent 16 is deposited on part of the base covered by the body.
  • the base was made of polyvinylchloride (PVC).
  • the electrodes were applied by screen coating with one, the working electrode, being of carbon and the other, the reference or counter electrode, being of silver, surface treated to provide a coating of silver chloride.
  • the capillary body was made of 0.5 mm thick PVA foam (Grade PRO/800; Prosthex Ltd., Surrey, England).
  • the layers 13 and 15 were made of adhesive electrical insulating (PVC) tape and polymethylmethacr late (Perspex), respectively. Reagent compositions differed between the embodiments for the purposes of respectively different analyses.
  • the instrument 20 can be of any suitable form adapted for cooperation with the reactor. Clearly it will have a socket 21 or other connector for mutual engagement or other working cooperation with the exposed electrode assembly portion of the reactor.
  • the instrument includes electronic components operable to respond to a representative potential difference set up between the reactor electrodes under the influence of the analytical reaction and to indicate that difference, or a resultant current flow, as a quantified output at a visual display 22.
  • the instrument can also include components operable to render the former fully operable in response to use of a reactor connected therewith, such as by reaction to liquid application.
  • other components can effect temperature compensation, switch between a range of operational modes in response to differential coding incorporated in reactors of different analytical type, and effect other useful functions.
  • Assay 1 This assay was carried out for glucose.
  • the carbon working electrode of the reactor was doped with 1 ,1 '-dimethyl- ferrocene and had the enzyme glucose oxidase immobilised on to it.
  • Glucose solutions were made up in phosphate buffered saline and allowed to stand overnight.
  • Assays were carried out by touching the surface of the glucose solution with the opening end of the reactor. This caused the solution to wick up the capillary body and come into contact with the electrodes to provide a response which was almost instantaneous.
  • This response was in the form of a potential difference across the reactor and this was applied to an instrument in the form of a 4700 ⁇ F capacitor deployed to integrate the relevant voltage for two minutes.
  • Such an embodiment can be useful to carry out glucose and other determinations in physiological fluids like blood.
  • a filter in the reactor enclosure, between the capillary body and opening, as indicated at 17 in Figure 1.
  • This filter is effective to remove unwanted materials such as red blood cells from the incoming sample.
  • Such an embodiment may usefully be integrated with a lance or other implement useful in providing a blood or other sample. Similar considerations might also apply to other materials for analysis, such as certain foods. These, for example jam, are often viscous and not amenable to normal analytical techniques.
  • a filter into the reactor, it is possible selectively to isolate the free-flowing component and carry out an assay on this.
  • Assay 2 This assay was carried out for ethanol . It is described here as an example of an analytical reaction that involves a soluble co-enzyme (NAD).
  • the reactor embodiment involved the enzymes alcohol dehydrogenase (10 mg ml -1 ) and diaphorase (2 mg ml -1 ), the co-enzyme NAD (10 mg ml -1 ), and the electron acceptor potassium ferricyanide (40 mg m1 -1 ), immobilised in 1:1 polyvinyl- pyrrolidone (made up with 0.2 M pyrophosphate buffer, pH 9.0) on the reactor base. When an aqueous solution of ethanol was drawn into the reactor, the reagents were dissolved.
  • Ferricyanide is reduced to ferrocyanide as shown in Figure 3. This was detected electrochemical ly at the working electrode. Again, the voltage resulting from the analytical reaction was used to charge up a capacitor, the voltage across the capacitor after two minutes was plotted against the concentration of ethanol, and the resultant operational characteristic is shown in Figure 4. Assay 3. This assay was carried out for aluminium and it is described here as an example of an analytical reaction that involves enzyme inhibition.
  • the reactor embodiment involved the enzymes hexokinase (40 ⁇ g ml " , diaphorase (2 mg ml -1 ), and glucose 6-phosphate-dehydrogenase ( 20 ⁇ l ml -1 ) and the co-enzyme NADP (lO g ml -1 ), immobilised in 1:1 polyvinylpyrrol idone (made up in 1.25 M imidazole buffer, pH 6.9, containing 1 mM magnesium chloride), on the reactor base.
  • hexokinase 40 ⁇ g ml "
  • diaphorase 2 mg ml -1
  • glucose 6-phosphate-dehydrogenase 20 ⁇ l ml -1
  • NADP co-enzyme NADP
  • the substrates adenosine triphosphate (15 mg ml -1 ) and glucose (50 mg ml -1 ) and the electron acceptor ferricyanide (80 mg ml -1) were immobilised in 1:1 polyvinylpyrrolidone ( made up in 1.25 M imidazole buffer, pH 6.9, that contained 1 mM magnesium chloride) on the inner face of the enclosure.
  • polyvinylpyrrolidone made up in 1.25 M imidazole buffer, pH 6.9, that contained 1 mM magnesium chloride
  • the reagents dissolve in it and ferricyanide is reduced to ferrocyanide as shown in Figure 5.
  • the reaction was allowed to proceed for five minutes.
  • Ferrocyanide was detected electrochemical ly with the resultant voltage being applied to charge up a capacitor.
  • the integrated capacitor voltage after one minute was plotted against the concentration of aluminium to give a characteristic as shown in Figure 6.
  • the reactor can accommodate a sequence of reactions involving the same sample, with an associated instrument giving individual and/or, if appropriate, composite quantitative results for the respective analytical reactions.
  • the reactor base can have the appropriate reagents applied thereto as respective transverse bands in a successively spaced assay along the base so that the reagents are mobilised in sequence as liquid is drawn into the capillary body.
  • plural capillary body channels leading to a common site can be provided, as proposed in Patent Specification WO 90/11519.
  • an alternative reactor form involves a compressed or otherwise liquid-expansible capillary body.
  • a compressed or otherwise liquid-expansible capillary body can expand when activated by the application of liquid to trap a thin film of the liquid against the associated electrodes.
  • such an expansion can be used to close off the enclosure adjacent the opening to prevent, or at least reduce, outward leaching.

Abstract

A disposable reactor (10) is provided for use with a co-operating instrument (20) to form an analytical device. The reactor includes a body of capillary material (14) housed in an enclosure (11, 15) having an opening for application of liquid to the body. At least one reagent (16) is immobilised in the enclosure. Also an electrode assembly (12, 12) passes through the enclosure, with one portion of the assembly extending within the enclosure to engage the capillary body and another portion of the assembly extending outside the enclosure, remotely from the enclosure opening, for connection with the associated instrument.

Description

ANALYTICAL DEVICES
Analytical devices for extralaboratory use are coming into greatly increased usage and they are, at the same time, becoming available in an increasing variety. This is particularly true of such devices related to medicine, but not exclusively so.
These devices are preferably of a self-contained form, typically requiring only the application of a sample of a body fluid such as urine or blood, for example. However, the devices are mostly of a qualitative or semi-qualitative form requiring some ability on the part of the user to interpret the analytical result. Because the user is commonly not skilled for this last purpose, and in fact is often a lay individual, the user-dependent nature of the devices makes them less than completely satisfactory.
This situation is reflected by the fact that a trend can be seen in favour of devices of a quantitative form and the invention concerns such devices.
The present invention particularly concerns quantitative devices of a two-part form involving a reusable instrument co-operable with disposable analytical reactors. More particularly, the invention concerns such two-part devices in which the reactor involves a body of capillary material carrying at least one immobilised reagent and engaging an electrode assembly connectable with an associated instrument. In use, a sample for analysis, and liquid to mobilise the reagent or reagents, are applied to the capillary body and the resultant reaction influences the electrode assembly in a manner dependent on the sample to provide a related quantitative output from the instrument. Such a device and use offers several advantages but, as so far proposed, also suffers from some disadvantages associated with the capillary body.
One of these disadvantages is that, unless the capillary body is compact, reagent can be mobilised in an undesirable manner to create areas of significantly different reagent concentrations. Another disadvantage is that, if the mobilising liquid is applied by dipping the body into a liquid reservoir, which is attractive for its simplicity, reagent can be leached from the body into the reservoir and impair the desired reaction. A further disadvantage is that the liquid contents of the body can be adversely affected by movement of the body such as occur, for example, with dipping.
An object of the present invention is to reduce these disadvantages and, to this end, the invention provides a disposable reactor for use with a co-operable instrument to form a quantitative analytical device, the reactor comprising a body of capillary material, a liquid-impermeable enclosure housing the capillary body and having an opening for application of liquid to the body, at least one reagent immobilised within the enclosure, and an electrode assembly passing through the enclosure, with one portion of the assembly extending within the enclosure to engage the capillary body and another portion of the assembly extending outside the enclosure, remotely from the enclosure opening, for connection with the associated instrument. A reagent can be immobilised in the enclosure by impregnation or other incorporation in the capillary body and/or by deposition on or other incorporation in the interior of the enclosure.
Preferably the enclosure and the housed capillary body, are of an elongate form with the opening at one end of the enclosure and the electrode assembly passing through the opposite end. Such a form suitably involves a strip base for the enclosure, an electrode assembly extending longitudinally along one side face of the base, a capillary body also of strip form and located on the base as well as one end portion, but not the other, of the electrode assembly, and an enclosure cover extending transversely over the body and connected with the base while leaving the electrode assembly other end portion exposed. The electrode assembly can in fact be directly covered with a layer of electrically insulating material over much of its length provided that it is exposed towards its ends respectively for operable engagement with the capillary body and an associated instrument.
The above-described and other facets of the invention are clarified by the following further description, given by way of example, of the accompanying drawings in which:-
Figure 1 schematically illustrates in exploded manner one form of a reactor according to the invention together with an associated instrument.
Figure 2 illustrates the results obtained for one form of ana tical assay effected with a particular embodiment of the reactor of Figure 1 ,
Figure 3 illustrates the reactions involved in another form of assay,
Figure 4 illustrates results obtained for the assay of Figure 3 with another reactor embodiment, and
Figures 5 and 6 respectively illustrate yet another assay and results associated with a further reactor embodiment.
Figure 1 the reactor and associated instrument are denoted general ly at 10 and 20. The reactor 10 has a base 11 of strip form made of material which is liquid impermeable and electrically insulating. An electrode assembly consisting of two mutually spaced parallel electrodes 12 are mounted longitudinally on one face of the base and have an intermediate portion of their length covered by a layer 13 of further impermeable insulating material to leave the electrodes exposed at their extremities. A body 14 of capillary material is, in turn, located to cover the exposed electrodes at one extremity. The body 14 is itself covered by a further layer 15 of impermeable insulating material which extends transversely round the body to connect with the base, while leaving exposed the end of the body remote from layer 13. Lastly, at least one reagent 16 is deposited on part of the base covered by the body.
In several different embodiments of this reactor form constructed during initial development of the invention, the base was made of polyvinylchloride (PVC). The electrodes were applied by screen coating with one, the working electrode, being of carbon and the other, the reference or counter electrode, being of silver, surface treated to provide a coating of silver chloride. The capillary body was made of 0.5 mm thick PVA foam (Grade PRO/800; Prosthex Ltd., Surrey, England). The layers 13 and 15 were made of adhesive electrical insulating (PVC) tape and polymethylmethacr late (Perspex), respectively. Reagent compositions differed between the embodiments for the purposes of respectively different analyses.
The instrument 20 can be of any suitable form adapted for cooperation with the reactor. Clearly it will have a socket 21 or other connector for mutual engagement or other working cooperation with the exposed electrode assembly portion of the reactor. Typically the instrument includes electronic components operable to respond to a representative potential difference set up between the reactor electrodes under the influence of the analytical reaction and to indicate that difference, or a resultant current flow, as a quantified output at a visual display 22. The instrument can also include components operable to render the former fully operable in response to use of a reactor connected therewith, such as by reaction to liquid application. In addition, other components can effect temperature compensation, switch between a range of operational modes in response to differential coding incorporated in reactors of different analytical type, and effect other useful functions.
Turning to the more specific detail of embodiments of the invention used for three different assays of analytical significance, materials used were as follows:- Alcohol dehydrogenase (EC 1.1.1.1.), diaphorase (EC 1.8.1.4) type II-L, glucose oxidase (EC 1.1.3.4) type X, glucose-6-phosphate dehydrogenase (EC 1.1.1.49) type VII, hexokinase (EC 2.7.1.1) type III, adenosine triphosphate (dipotassiu salt), 3-nicotinamide adenine dinucleotide (NAD) sodium salt and β-nicotinamide adenine dinucleotide phosphate (NADP) sodium salt, from the Sigma Chemical Co. Poole, Dorset, England. Diaphorase (EC 1.8.1.4) type II from Boehringer Mannheim UK, Lewes, East Sussex, England. Aluminium nitrate nonahydrate (99.9999%), magnesium chloride hexahydrate (99.995%) and 1 , 1 '-dimethyl-ferrocene from the Aldrich Chemical Co., Gillingham, Dorset, England. Imidazole (extra pure) from BDH Chemical Co., Poole, Dorset, England. Polyvinylpyrrol idone (Av. Mr. 10 kda.) from Fluka Chemicals Ltd., Glossop, Derbyshire, England. Potassium ferricyanide from Fissons Ltd., Loughborough, Leicestershire, England. 1:1 solutions of polyvinylpyrrol idone were prepared by adding one part by weight polyvinylpyrrol idone to one part by weight of buffer solution and mixing until a smooth paste was formed.
Assay 1. This assay was carried out for glucose. The carbon working electrode of the reactor was doped with 1 ,1 '-dimethyl- ferrocene and had the enzyme glucose oxidase immobilised on to it. Glucose solutions were made up in phosphate buffered saline and allowed to stand overnight. Assays were carried out by touching the surface of the glucose solution with the opening end of the reactor. This caused the solution to wick up the capillary body and come into contact with the electrodes to provide a response which was almost instantaneous. This response was in the form of a potential difference across the reactor and this was applied to an instrument in the form of a 4700 μF capacitor deployed to integrate the relevant voltage for two minutes. At the end of this time the voltage across the capacitor was determined using a multimeter. This was plotted against glucose concentration in the sample solution to give a result indicated by Figure 2. Such an embodiment can be useful to carry out glucose and other determinations in physiological fluids like blood. For this purpose it can be appropriate to incorporate a filter in the reactor enclosure, between the capillary body and opening, as indicated at 17 in Figure 1. This filter is effective to remove unwanted materials such as red blood cells from the incoming sample. Also such an embodiment may usefully be integrated with a lance or other implement useful in providing a blood or other sample. Similar considerations might also apply to other materials for analysis, such as certain foods. These, for example jam, are often viscous and not amenable to normal analytical techniques. However, with the incorporation of a filter into the reactor, it is possible selectively to isolate the free-flowing component and carry out an assay on this.
Assay 2. This assay was carried out for ethanol . It is described here as an example of an analytical reaction that involves a soluble co-enzyme (NAD). For this purpose, the reactor embodiment involved the enzymes alcohol dehydrogenase (10 mg ml-1) and diaphorase (2 mg ml-1), the co-enzyme NAD (10 mg ml-1), and the electron acceptor potassium ferricyanide (40 mg m1-1), immobilised in 1:1 polyvinyl- pyrrolidone (made up with 0.2 M pyrophosphate buffer, pH 9.0) on the reactor base. When an aqueous solution of ethanol was drawn into the reactor, the reagents were dissolved. Ferricyanide is reduced to ferrocyanide as shown in Figure 3. This was detected electrochemical ly at the working electrode. Again, the voltage resulting from the analytical reaction was used to charge up a capacitor, the voltage across the capacitor after two minutes was plotted against the concentration of ethanol, and the resultant operational characteristic is shown in Figure 4. Assay 3. This assay was carried out for aluminium and it is described here as an example of an analytical reaction that involves enzyme inhibition. For this purpose the reactor embodiment involved the enzymes hexokinase (40 μg ml" , diaphorase (2 mg ml-1), and glucose 6-phosphate-dehydrogenase (20 μl ml-1) and the co-enzyme NADP (lO g ml-1), immobilised in 1:1 polyvinylpyrrol idone (made up in 1.25 M imidazole buffer, pH 6.9, containing 1 mM magnesium chloride), on the reactor base. Also, the substrates adenosine triphosphate (15 mg ml-1) and glucose (50 mg ml-1) and the electron acceptor ferricyanide (80 mg ml-1) were immobilised in 1:1 polyvinylpyrrolidone (made up in 1.25 M imidazole buffer, pH 6.9, that contained 1 mM magnesium chloride) on the inner face of the enclosure. When such a reactor draws up an acidic aqueous solution of aluminium nitrate (made by dissolving aluminium nitrate in 10 mM nitric acid) the reagents dissolve in it and ferricyanide is reduced to ferrocyanide as shown in Figure 5. The reaction was allowed to proceed for five minutes. Ferrocyanide was detected electrochemical ly with the resultant voltage being applied to charge up a capacitor. The integrated capacitor voltage after one minute was plotted against the concentration of aluminium to give a characteristic as shown in Figure 6.
While the invention has been described with more particular reference to the illustrated reactor form and assay-specific embodiments thereof, it is clearly open to considerable variation within the broader introductory description.
For example, the reactor can accommodate a sequence of reactions involving the same sample, with an associated instrument giving individual and/or, if appropriate, composite quantitative results for the respective analytical reactions. For this purpose the reactor base can have the appropriate reagents applied thereto as respective transverse bands in a successively spaced assay along the base so that the reagents are mobilised in sequence as liquid is drawn into the capillary body. Alternatively, or in addition, plural capillary body channels leading to a common site can be provided, as proposed in Patent Specification WO 90/11519.
In another example, an alternative reactor form involves a compressed or otherwise liquid-expansible capillary body. Such a body can expand when activated by the application of liquid to trap a thin film of the liquid against the associated electrodes. Also, such an expansion can be used to close off the enclosure adjacent the opening to prevent, or at least reduce, outward leaching. Similarly, it is possible to close the opposite end of the enclosure if it is not already otherwise so.

Claims

1. A disposable reactor for use with a co-operable instrument to form a quantitative analytical device, which reactor comprises a body of capillary material, a liquid-impermeable enclosure housing the capillary body and having an opening for application of liquid to the body, at least one reagent immobilised within the enclosure, and an electrode assembly passing through the enclosure, with one portion of the assembly extending within the enclosure to engage the capillary body and another portion of the assembly extending outside the enclosure, remotely from the enclosure opening, for connection with the associated instrument.
2. A reactor according to Claim 1 wherein said enclosure and capillary body are each of elongate form with said opening at one end of the enclosure and said electrode assembly passing through the opposite end.
3. A reactor according to Claim 2 comprising a strip base for said enclosure, with said electrode assembly extending longitudinally along one side face of said base, said capillary body being also of strip form and located on said base as well as one end portion, but not the other, of said electrode assembly, and an enclosure cover extending transversely over said body and connected with said base while leaving said electrode assembly other end portion exposed.
4. A reactor according to Claim 3 wherein said electrode assembly comprises two electrodes extending in mutually spaced side-by-side manner along said base.
5. A reactor according to Claim 3 or 4 wherein said electrode assembly is directly covered with a layer of electrically insulating material except at its ends for operable engagement with said body and instrument.
6. A reactor according to any preceding claim comprising a filter located in said enclosure between said capillary body and said opening.
7. A reactor according to any preceding claim comprising a reagent immobilised within said enclosure by impregnation in said capillary body.
8. A reactor according to any preceding claim comprising a reagent immobilised within said enclosure by deposition in the interior thereof.
PCT/GB1992/000576 1991-04-05 1992-04-01 Analytical devices WO1992017778A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4506950A JPH06506144A (en) 1991-04-05 1992-04-01 Analysis equipment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9107193.6 1991-04-05
GB9107193A GB9107193D0 (en) 1991-04-05 1991-04-05 Analytical devices

Publications (1)

Publication Number Publication Date
WO1992017778A1 true WO1992017778A1 (en) 1992-10-15

Family

ID=10692707

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/000576 WO1992017778A1 (en) 1991-04-05 1992-04-01 Analytical devices

Country Status (5)

Country Link
EP (1) EP0578669A1 (en)
JP (1) JPH06506144A (en)
GB (2) GB9107193D0 (en)
IE (1) IE921071A1 (en)
WO (1) WO1992017778A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
GB2365123A (en) * 2000-07-20 2002-02-13 Hypoguard Ltd Test strip
US6827899B2 (en) 2000-08-30 2004-12-07 Hypoguard Limited Test device
US6942769B2 (en) 2003-08-05 2005-09-13 Bt Medical Corp. Electrochemical sensor strip with low porosity screen
US7138089B2 (en) 2000-07-20 2006-11-21 Hypoguard Limited Test device for analyzing blood glucose or other analytes in bodily fluids
WO2007054850A2 (en) * 2005-11-09 2007-05-18 Koninklijke Philips Electronics N.V. Device for testing a fluid
US7416699B2 (en) 1998-08-14 2008-08-26 The Board Of Trustees Of The Leland Stanford Junior University Carbon nanotube devices
WO2009027935A2 (en) * 2007-08-31 2009-03-05 Koninklijke Philips Electronics N. V. Biochemical sensor cartridge
US8550295B2 (en) 2010-02-22 2013-10-08 Roche Diagnostics Operations, Inc. Container for dispensing a single test strip
US9039974B2 (en) 2011-02-02 2015-05-26 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device
WO2015136154A1 (en) * 2014-03-13 2015-09-17 Kari Kolehmainen Test strip and apparatus for measuring the content of alcohol in blood, or of any other substance in blood, and a method for measuring the content of alcohol in blood

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
JP3394262B2 (en) 1997-02-06 2003-04-07 セラセンス、インク． Small volume in vitro analyte sensor
US6635167B1 (en) * 1997-12-04 2003-10-21 Roche Diagnostics Corporation Apparatus and method for determining the concentration of a component of a sample
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
JP3389106B2 (en) 1998-06-11 2003-03-24 松下電器産業株式会社 Electrochemical analysis element
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
BR9915637A (en) * 1998-11-30 2001-11-06 Abbott Lab Measuring device for multiple chemicals and test strips
US6773671B1 (en) 1998-11-30 2004-08-10 Abbott Laboratories Multichemistry measuring device and test strips
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
EP1712919B1 (en) * 2004-01-07 2012-08-15 ARKRAY, Inc. Analytical instrument having improved arrangement of reagent section and analytical method
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
WO2011026147A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
AU2012335830B2 (en) 2011-11-07 2017-05-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2127142A1 (en) * 1970-06-08 1971-12-16 Miles Lab Analyzer
EP0121385A1 (en) * 1983-03-26 1984-10-10 Cambridge Life Sciences Plc Conductimetric bioassay techniques
EP0136362A1 (en) * 1983-03-11 1985-04-10 Matsushita Electric Industrial Co., Ltd. Biosensor
EP0230472A1 (en) * 1985-06-21 1987-08-05 Matsushita Electric Industrial Co., Ltd. Biosensor and method of manufacturing same
EP0127958B1 (en) * 1983-05-05 1992-03-11 MediSense, Inc. Sensor electrode systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273639A (en) * 1979-06-20 1981-06-16 Eastman Kodak Company Capillary bridge in apparatus for determining ionic activity
US4549952A (en) * 1982-11-22 1985-10-29 Eastman Kodak Company Capillary transport device having means for increasing the viscosity of the transported liquid
AU581669B2 (en) * 1984-06-13 1989-03-02 Applied Research Systems Ars Holding N.V. Photometric instruments, their use in methods of optical analysis, and ancillary devices therefor
EP0230645A3 (en) * 1985-12-28 1987-12-09 Fuji Photo Film Co., Ltd. Ionic activity measuring device
JP2514083B2 (en) * 1986-11-28 1996-07-10 ユニリーバー・ナームローゼ・ベンノートシヤープ Electrochemical measuring device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2127142A1 (en) * 1970-06-08 1971-12-16 Miles Lab Analyzer
EP0136362A1 (en) * 1983-03-11 1985-04-10 Matsushita Electric Industrial Co., Ltd. Biosensor
EP0121385A1 (en) * 1983-03-26 1984-10-10 Cambridge Life Sciences Plc Conductimetric bioassay techniques
EP0127958B1 (en) * 1983-05-05 1992-03-11 MediSense, Inc. Sensor electrode systems
EP0230472A1 (en) * 1985-06-21 1987-08-05 Matsushita Electric Industrial Co., Ltd. Biosensor and method of manufacturing same

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
US7416699B2 (en) 1998-08-14 2008-08-26 The Board Of Trustees Of The Leland Stanford Junior University Carbon nanotube devices
GB2365123A (en) * 2000-07-20 2002-02-13 Hypoguard Ltd Test strip
US7138089B2 (en) 2000-07-20 2006-11-21 Hypoguard Limited Test device for analyzing blood glucose or other analytes in bodily fluids
US6827899B2 (en) 2000-08-30 2004-12-07 Hypoguard Limited Test device
US6942769B2 (en) 2003-08-05 2005-09-13 Bt Medical Corp. Electrochemical sensor strip with low porosity screen
WO2007054850A3 (en) * 2005-11-09 2007-09-27 Koninkl Philips Electronics Nv Device for testing a fluid
WO2007054850A2 (en) * 2005-11-09 2007-05-18 Koninklijke Philips Electronics N.V. Device for testing a fluid
US7955558B2 (en) 2005-11-09 2011-06-07 Koninklijke Philips Electronics N.V. Device for testing a fluid
WO2009027935A2 (en) * 2007-08-31 2009-03-05 Koninklijke Philips Electronics N. V. Biochemical sensor cartridge
WO2009027935A3 (en) * 2007-08-31 2009-06-25 Koninkl Philips Electronics Nv Biochemical sensor cartridge
US8550295B2 (en) 2010-02-22 2013-10-08 Roche Diagnostics Operations, Inc. Container for dispensing a single test strip
US9039974B2 (en) 2011-02-02 2015-05-26 Panasonic Healthcare Holdings Co., Ltd. Biological sample measuring device
WO2015136154A1 (en) * 2014-03-13 2015-09-17 Kari Kolehmainen Test strip and apparatus for measuring the content of alcohol in blood, or of any other substance in blood, and a method for measuring the content of alcohol in blood

Also Published As

Publication number Publication date
GB2254436A (en) 1992-10-07
GB2254436B (en) 1994-08-17
GB9107193D0 (en) 1991-05-22
EP0578669A1 (en) 1994-01-19
IE921071A1 (en) 1992-10-07
GB9207169D0 (en) 1992-05-13
JPH06506144A (en) 1994-07-14

Similar Documents

Publication Publication Date Title
WO1992017778A1 (en) Analytical devices
US4356074A (en) Substrate specific galactose oxidase enzyme electrodes
US6254736B1 (en) Method of selectively increasing the hydrophilicity of a web
US5217594A (en) Convenient determination of trace lead in whole blood and other fluids
EP0636879B1 (en) Method for producing a biosensor
US6258229B1 (en) Disposable sub-microliter volume sensor and method of making
CA2481426C (en) Disposable sub-microliter volume biosensor with enhanced sample inlet
JP2838484B2 (en) Biosensor for gas measurement and method for producing the same
AU6157898A (en) Small volume (in vitro) analyte sensor
JP2001208716A (en) Microsphere including sensor
AU583349B2 (en) Electrochemical assay for cis-diols
JP2002514744A5 (en)
KR20030038664A (en) Electrochemical method for measuring chemical reaction rates
JPH08511942A (en) Stabilizer for diagnostic reagents
HK1027623A1 (en) Biosensor comprising a lipid membrane containing gated ion channels
CA2543010A1 (en) Enzymatic electrochemical biosensor
US3654180A (en) Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone
EP1225449B1 (en) Non-enzymatic disposable electrode strip comprising a surfactant for detecting uric acid or hemoglobin; method for producing the same and its use
KR970001814B1 (en) Process for measuring the content of component in vital fluid
JPH03160358A (en) Enzyme sensor
JPS58216947A (en) Enzyme electrode for measuring sucrose concentration
Wolff et al. Nonmembrane amperometric sensor for dissolved oxygen in flow-through systems
AU2006202499B2 (en) Improved electrochemical biosensor test strip
JPH0810207B2 (en) Biosensor
AU2005202280B2 (en) Improved electrochemical biosensor test strip

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: US

Ref document number: 1993 129112

Date of ref document: 19931005

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1992907175

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992907175

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992907175

Country of ref document: EP